Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence

SARS-CoV-2 has infected over 200 million and caused more than 4 million deaths to date. Most individuals (>80%) have mild symptoms and recover in the outpatient setting, but detailed studies of immune responses have focused primarily on moderate to severe COVID-19. We deeply profiled the longitud...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:bioRxiv
Autori principali: Talla, Aarthi, Vasaikar, Suhas V., Lemos, Maria P., Moodie, Zoe, Lee Pebworth, Mark-Phillip, Henderson, Kathy E., Cohen, Kristen W., Czartoski, Julie L., Lai, Lilin, Suthar, Mehul S., Heubeck, Alexander T, Genge, Palak C., Roll, Charles R., Weiss, Morgan, Reading, Julian, Kondza, Nina, MacMillan, Hugh, Fong, Olivia C., Thomson, Zachary James, Graybuck, Lucas T., Okada, Lauren Y., Newell, Evan W., Coffey, Ernest M., Meijer, Paul, Becker, Lynne A., De Rosa, Stephen C., Skene, Peter J., Torgerson, Troy R., Li, Xiao-jun, Szeto, Gregory Lee, McElrath, M. Juliana, Bumol, Thomas F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Cold Spring Harbor Laboratory 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168393/
https://ncbi.nlm.nih.gov/pubmed/34075380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.05.26.442666
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi